STOCK TITAN

Royalty Pharma (RPRX) holder TPC RP EPA1 LLC eyes 11,002-share stock sale

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

TPC RP EPA1 LLC, an affiliate stockholder of Royalty Pharma plc (symbol RPRX), filed a notice of proposed sale of 11,002 shares of common stock through Goldman Sachs & Co. LLC. The shares were acquired on 08/05/2026 as compensation under performance awards from the issuer.

The filing also lists a prior transaction in the last three months, where TPC RP EPA1 LLC sold 64,399 shares of common stock on 05/26/2026 for an aggregate amount of $3,476,118.96.

Positive

  • None.

Negative

  • None.
Shares proposed for sale 11,002 shares of common stock Securities to be sold as listed in the Form 144 notice
Shares sold in past 3 months 64,399 shares of common stock Securities sold on 05/26/2026 during the past 3 months
Aggregate amount from prior sale $3,476,118.96 Aggregate amount for 64,399 shares sold on 05/26/2026
Acquisition date of compensation shares 08/05/2026 Date 11,002 shares were acquired as compensation via performance awards
Planned sale reference date 08/13/2026 Date associated with common stock entry and NASD trading line
Securities To Be Sold regulatory
"144: Securities To Be Sold Common Stock | 08/05/2026 | Acquired as compensation"
Securities Sold During The Past 3 Months regulatory
"144: Securities Sold During The Past 3 Months TPC RP EPA1 LLC 110 East 59th Street"
Performance Awards financial
"Acquired as compensation -- Performance Awards | The Issuer | | | 11002"

FAQ

What stock sale is TPC RP EPA1 LLC planning for RPRX under this Form 144?

TPC RP EPA1 LLC filed to potentially sell 11,002 shares of Royalty Pharma (RPRX) common stock. The notice lists Goldman Sachs & Co. LLC as broker and identifies the shares as acquired as compensation via performance awards on 08/05/2026.

How many RPRX shares did TPC RP EPA1 LLC sell in the last three months?

The filing reports that TPC RP EPA1 LLC sold 64,399 shares of RPRX common stock on 05/26/2026. The aggregate sale amount for this transaction is disclosed as $3,476,118.96.

How were the RPRX shares to be sold by TPC RP EPA1 LLC acquired?

The 11,002 RPRX shares proposed for sale were acquired as compensation on 08/05/2026. The filing specifies they came from performance awards granted by the issuer as part of compensation.

Which broker is handling the proposed RPRX share sale for TPC RP EPA1 LLC?

The proposed sale of 11,002 RPRX common shares will be handled by Goldman Sachs & Co. LLC. The broker’s address is listed as 200 West Street, New York, NY 10282, with trading noted on NASD.

What is the aggregate dollar value disclosed for recent RPRX stock sales?

For the sale on 05/26/2026, TPC RP EPA1 LLC reports an aggregate amount of $3,476,118.96. This corresponds to the disposition of 64,399 RPRX common shares during the past three months.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature